Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (DRKS00041105) titled 'PsoChoice - Development of a digital tool to support an individualized, patient-centered selection of systemic therapies for psoriasis vulgaris' on July 24.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: other
Primary Sponsor: Klinik fur Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover
Condition:
L40.9
Psoriasis, unspecified
Intervention:
Group 1: Observational study: Patients with moderate-to-severe psoriasis vulgaris who are scheduled to start or switch to systemic therapy. At therapy initiation (routine care), demographic an...